The influence of field size and other radiotherapy parameters on acute toxicity in pharyngolaryngeal cancers

Strahlentherapie und Onkologie

Volumn 175, Issue 2, 1999, Pages 74-77

  Miralbell, Raymond ^a,b   Allal, Abdelkarim S ^b   Mermillod, Bernadette ^a   Pastoors, Bert ^b  

^a Radiation Oncology Department   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Acute toxicity; Head and neck cancer; Radiotherapy

Indexed keywords

ARTICLE; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; LARYNX; MAJOR CLINICAL STUDY; PHARYNX; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RISK ASSESSMENT;

EID: 0033007328     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02753846     Document Type: Article

References (14)

1. Allai AS, Miralbell R, Pipard G, et al. Early and long-term results of an original accelerated radiation therapy schedule in head and neck carcinoma. Acta Oncol 1997;36:267-71.
2. Allai AS, Bieri S, Miralbell R, et al. Combined concomitant boost radiotherapy and chemotherapy in stage-III-IV head and neck carcinomas: A comparison of toxicity and treatment results with those observed after radiotherapy alone. Ann Oncol 1997;8:681-4.
3. Barendsen GW. Dose fractionation, dose rate and isoeffect relationships for normal tissue response. Int J Radiat Oncol Biol Phys 1982;8:1981-97.
4. Dale RG. Time-dependent tumor repopulation factors in linear-quadratic equations. Implications for treatment strategies. Radiother Oncol 1989; 15371-82.
5. Douglas BG. Implications of the quadratic cell survival curve and human skin radiation "tolerance doses" on fractionation and superfrac-tionation dose selection. Int J Radiat Oncol Biol Phys 1982;8: 1135-42.
6. Horiot J-C, Bontemps P, Bogaert W van den, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997;44: 111-21.
7. Jackson SM, Weir LM, Hay JH, et al. A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997;43:39-46.
8. Leyvraz S, Pasche P, Bauer J, et al. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: Four-year results of a phase-I/II study. J Clin Oncol 1994;12:1876-85.
9. Orton CO, Cohen L. A unified approach to dose-effect relationships in radiotherapy. I: Modified TDF and linear quadratic equations. Int J Radiat Oncol Biol Phys 19S8;14:549-56.
10. Overgaard J, Sand Hansen H, Overgaard M, et al. Conventional radiotherapy as primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week. Report from the DAHANCA 7 trial. Int J Radiat Oncol Biol Phys 1997;39 Suppl:188.
11. Paterson R. Influence of tolerance on choice of dose. In: Arnold E, ed. The treatment of malignant disease by radium and x-rays. London: Publishers Ltd, 1948:39.
12. Ferez CA, Brady LW. Overview. In: Ferez CA, Brady LW, eds. Principles and practice of radiation oncology. Philadelphia: Lippincott, 1992:51-5.
13. Wang CC, Blitzer PH, Suit HD. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985;55:2100-4.
14. Weissler MC, Melin S, Sailer SL, et al. Simultaneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1992;118:806-10.